Logo
LUMIFIL Lite with Lidocaine 1 x 1ml

LUMIFIL Lite with Lidocaine 1 x 1ml

LUMIFIL

Dermal filler
  • LUMIFIL L Lite is described by several authorised distributors as CE Marked, indicating compliance with relevant European medical device standards.
  • Manufactured by BNC Korea, a facility referenced in distributor documentation; CE / ISO Certification typically required for international distribution.
  • Proudly marketed for professional use only; regulatory compliance should be verified via physical packaging, batch labelling, IFU and current national device registries before clinical use or marketing.
Low-viscosity hyaluronic acid filler for fine lines / subtle volume

Description

LUMIFIL Lite with Lidocaine is a low-viscosity, ultra-fine hyaluronic acid dermal filler supplied in a 1 ml pre-filled syringe. It is designed for subtle volumising and correction of fine lines – such as crow’s feet, perioral lines, light forehead wrinkles – and for delicate areas including lips (standard or Russian lip technique), under-eye or tear-trough, and shallow wrinkles. The filler uses cross-linked HA and includes 0.3% lidocaine to improve comfort during injection, offering smooth flow, easy moulding and natural-looking results with long-lasting effects.

Bnefits

  • Low-viscosity, ultra-fine HA gel ideal for delicate corrections and fine lines
  • High viscoelasticity ensuring stable volume and shape over time with minimal migration
  • Uniform particle size (via patented particle/PP process) for smooth injection and predictable moulding
  • Contains lidocaine (0.3%) to minimise injection pain and improve patient comfort
  • Provides subtle volume and contouring — suitable for fine wrinkles, lip augmentation, under-eye/tear‐trough, perioral lines, and light forehead lines
  • Allows precise, site-specific contouring and detailed work (e.g. for lips using Russian-Lip technique)
  • Low phase angle helps filler stay close to the injection site for longer effect
  • Traditionally reported duration of effect of around 12–15 months (person-specific)
  • CE-marked as part of the LUMIFIL filler range (per distributor data) for safety and quality compliance
  • Minimal swelling and downtime; natural, smooth finish without overfilling or stiffness

Indications

  • Fine lines and shallow wrinkles (crow’s feet, perioral / smoker’s lines, light forehead lines)
  • Subtle lip augmentation and reshaping, including techniques requiring precision such as “Russian Lip”
  • Under-eye / tear-trough correction and gentle volumisation of delicate facial areas
  • Subtle contouring and definition for superficial facial wrinkles or volume loss
  • Areas requiring fine detailing and natural, low-volume correction rather than deep structural augmentation

Composition

  • Cross-linked hyaluronic acid (HA) — derivation via microbial fermentation, non-animal sourced
  • HA concentration: 20 mg/ml (as per technical specifications listed by distributors)
  • Lidocaine hydrochloride 0.3% to reduce pain during injection
  • Physiological buffer / sterile saline vehicle and other sterile excipients (full excipient list declared in IFU, not publicly detailed)

Formulation

  • Monophasic, cross-linked HA gel with uniform particle size (via patented PP / 3D cross-linking technology) for smooth flow and stable integration.
  • Pre-filled 1 ml sterile syringe intended for intradermal or superficial dermal injection in indicated areas.
  • Includes 0.3% lidocaine for local anaesthesia during injection to reduce discomfort.

Packaging

  • 1 × 1 ml pre-filled sterile syringe (single-use) per pack.
  • Typically supplied with two sterile needles (e.g. 30G), as per standard filler packaging for LUMIFIL Lite products.
  • Packaged in a box with batch number, expiry date and IFU, as per medical device regulations

Usage

  • For professional use only by trained aesthetic practitioners or licensed healthcare professionals.
  • Intended for injection into superficial to mid-dermal layers depending on area and indication (e.g. fine lines, perioral lines, under-eye, lips).
  • Use slow, controlled injection with appropriate technique (e.g. serial puncture, linear threading or microbolus) depending on anatomical area and desired effect. Follow institution/clinic protocols and IFU guidelines.
  • Maintain aseptic technique: cleanse skin, disinfect, use sterile gloves and needles; avoid injection into vessels; aspirate as per clinic protocol.
  • After injection, gently mould if needed; advise patient on aftercare: avoid makeup & heavy pressure, excessive heat/cold, alcohol, strenuous exercise and sun exposure for at least 24 hours (or per clinic protocol).
  • Ensure proper waste disposal of used needles/syringes as per sharps regulations. Document batch number, consent, procedure details as per regulatory requirements.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid, lidocaine, or any component of the filler formulation (e.g. preservatives, excipients).
  • Active skin infection, inflammation, or disease at or near the intended injection site (e.g. acne flare, dermatitis, herpes simplex).
  • History of severe allergic reactions, anaphylaxis, or multiple severe allergies where elective injectables may be contraindicated. General injectable filler contraindications apply.
  • Pregnancy or breastfeeding (elective cosmetic filler use usually avoided in absence of safety data) — standard practice per aesthetic medicine guidelines (not always explicitly stated but implied).
  • Use in areas with previous permanent filler or implants where interactions may occur, unless evaluated safe by a qualified clinician.
  • Any other contraindications or precautions as specified in the official Instructions for Use (IFU) provided with the product.

Adverse Effects

  • Common, usually transient injection-related effects: redness, swelling, bruising, tenderness or mild discomfort at injection site; possible itching or mild induration.
  • Possible lumps, asymmetry or uneven results if injection or placement technique is suboptimal.
  • Risk of infection if aseptic protocols are not strictly followed; delayed inflammatory reactions or hypersensitivity possible (rare).
  • If inadvertently injected intravascularly, risk of vascular occlusion, tissue ischemia, necrosis or other vascular complications (as with all HA fillers). Practitioners must be trained for complication recognition and management. (Not unique to this product but applies broadly to injectable fillers.)
  • Patients should be counselled about possible downtime, risk of bruising/swelling, and given aftercare instructions; seek medical attention if unusual symptoms (e.g. severe pain, visual changes, persistent swelling, signs of infection) occur.

Storage Conditions

  • Store in original packaging, protected from extreme temperatures and direct sunlight. Multiple distributors indicate storage at room temperature (e.g. 1–30 °C) away from freezing.
  • Keep out of reach of unauthorised persons or children; for professional use only.
  • Do not use if packaging is damaged, syringe integrity compromised, product appears discoloured or contains particulates, or if expiry date has passed. Follow standard medical device and injectable storage guidelines.

Duration

Effect duration is typically quoted as approximately 12\u201315 months (person-specific), depending on the area treated, volume injected, and individual factors (e.g. metabolic rate).

Onset

Volumising and smoothing effects are visible immediately after injection; final settled results become apparent as any initial swelling or redness subsides within a few days.

Browse more Dermal filler

Top Treatments

Top Cities in the UK